Dr. King is a Professor of Pathology at The University of Sydney in Sydney, Australia. He is internationally recognized for his research on viral pathogenesis and immune pathology and is a co-inventor of the Cour immune modifying particle technology platform. Dr. King received his Bachelor of Medicine and Bachelor of Surgery from the University of Cape Town in 1976 and his PhD in 1986 from the Australian National University. After completing his post-doctoral training in the Research School of Physical Sciences at the Australian National University, he joined the Department of Anatomy at the University in 1988 and the Department of Pathology in 1991.
Most recently, Dr. King was admitted as an honorary member to the Royal College of Pathologists (2009). Dr. King has served as President of the Federation of Immunological Societies Asia-Oceania (FIMSA), Treasurer of the International Union of Immunology Societies, and Head of Department and Director of Sydney Cytometry — a state-of-the-art Core Facility at the University and the most advanced and largest flow cytometry unit in the Southern Hemisphere.